Partner, AIX Ventures
AI-enabled healthcare and life sciences investment partner
Krish Ramadurai is a Partner at AIX Ventures leading technical due diligence and investments in AI-enabled healthcare and life sciences. He holds dual master's degrees from Harvard and Washington University and is pursuing research at Oxford's Institute of Biomedical Engineering. He has led over 40 early and growth-stage investments and managed a portfolio exceeding $20B in enterprise value. He has backed over 20 major scientific breakthroughs including the world's first AI-designed drug in human trials.
Based in: San Francisco, USA (North America)